GASTRIC-MUCOSAL PROTECTION BY YM638, A NOVEL LEUKOTRIENE D-4 RECEPTOR ANTAGONIST, IN RATS

被引:2
|
作者
MIYATA, K
KAMATO, T
NISHIDA, A
TAKIZAWA, K
TAKEDA, M
机构
[1] Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, 305
关键词
YM638 ([[5-[[3-(4-ACETYL-3-HYDROXY-2-PROPYLPHENOXY)PROPYL]THIO]-1,3,4-THIADIAZOL-2-YL]THIO] ACETIC ACID); LEUKOTRIENE D-4 RECEPTOR ANTAGONIST; GASTRIC MUCOSAL PROTECTION; GASTRIC LESION;
D O I
10.1016/0014-2999(95)00035-J
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
YM638 ([[5-[[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propyl]thio]-1,3,4-thiadiazol-2-yl]thio] acetic acid) is a novel leukotriene D-4 receptor antagonist. We investigated the involvement of the leukotriene D-4 receptor blocking activity of YM638 in the gastric mucosal protection of this drug in rats. YM638 significantly prevented gastric lesion formation induced by water-immersion restraint stress, indomethacin, absolute ethanol, 0.7 N HCl and the combination of 0.2 N HCl and hemorrhagic shock, with ED(50) values of 26.4, 4.1, 4.7, 35.4 and 8.0 mg/kg p.o., respectively. Cetraxate and sofalcone showed inhibitory effects on most of these gastric lesions, but the inhibitory effects of these compounds were much weaker than those of YM638. In contrast, YM638 had no effect on gastric acid secretion and gastric lesion formation in pylorus-ligated rats, or on duodenal lesion formation in cysteamine-administered rats. YM638 competitively antagonized leukotriene D-4-induced contraction of the isolated stomach, with a pA(2) value of 7.63 +/- 0.18. In anesthetized rats, intravenous YM638 inhibited leukotriene D-4-induced aggravation of gastric lesions caused by HCl, and leukotriene D-4 and HCl-induced reduction of the potential difference. In addition, oral YM638 significantly increased gastric mucosal blood flow and prevented ethanol-induced increase in gastric vascular permeability. Endogenous prostaglandins, sulfhydryls and nitric oxides were not involved in this inhibitory effect on absolute ethanol-induced gastric lesion, YM638 did not react with the stable free radical 1,1-diphenyl-2-picrylhydrazyl in vitro, indicating that YM638 does not have potential as free radical scavenger. These results suggest that the preventive effect of YM638 on gastric lesions is attributable not only to its leukotriene D-4 receptor blocking activity but also to the activation of gastric mucosal defensive mechanisms such as mucosal blood flow and vascular permeability.
引用
收藏
页码:165 / 175
页数:11
相关论文
共 47 条
  • [31] Montelukast, a selective leukotriene D4 receptor antagonist, inhibits antigen-induced bronchoconstriction in brown Norway rats.
    Ihaku, D
    Suzuki, M
    Martin, JG
    Hamid, QA
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (01) : S135 - S135
  • [32] PHARMACOLOGY OF L-660,711 (MK-571) - A NOVEL POTENT AND SELECTIVE LEUKOTRIENE-D4 RECEPTOR ANTAGONIST
    JONES, TR
    ZAMBONI, R
    BELLEY, M
    CHAMPION, E
    CHARETTE, L
    FORDHUTCHINSON, AW
    FRENETTE, R
    GAUTHIER, JY
    LEGER, S
    MASSON, P
    MCFARLANE, CS
    PIECHUTA, H
    ROKACH, J
    WILLIAMS, H
    YOUNG, RN
    DEHAVEN, RN
    PONG, SS
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1989, 67 (01) : 17 - 28
  • [33] Picogram determination of a novel dopamine D-4 receptor antagonist in human plasma and urine by liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrometry
    ChavezEng, CM
    Constanzer, ML
    Matuszewski, BK
    JOURNAL OF CHROMATOGRAPHY B, 1997, 691 (01): : 77 - 85
  • [34] Role of nitric oxide and prostaglandin in the protective effect of pibutidine hydrochloride, a novel histamine H2-receptor antagonist, on the gastric mucosal lesions in rats
    Kiuchi, Y
    Isobe, Y
    Kijima, H
    Saitoh, T
    Higuchi, S
    GENERAL PHARMACOLOGY, 1998, 31 (02): : 271 - 275
  • [35] PROTECTION FROM D-GALACTOSAMINE-INDUCED LIVER-INJURY BY ORALLY-ACTIVE NOVEL PEPTIDE LEUKOTRIENE RECEPTOR ANTAGONIST, ONO-1078
    HAN, K
    HASHIMOTO, N
    IKEDA, Y
    MITSUI, H
    TODA, G
    YAMADA, H
    KOKUBUN, N
    WATANABE, T
    KUROKAWA, K
    INTERNATIONAL HEPATOLOGY COMMUNICATIONS, 1995, 4 (02): : 102 - 108
  • [36] Effects of RS-601, a novel leukotriene D4/thromboxane A2 dual receptor antagonist, on asthmatic responses in guinea pigs
    Yamada, T
    Takahashi, Y
    Ishizaki, M
    Musoh, K
    Ohashi, T
    Tanaka, H
    Inagaki, N
    Nagai, H
    PHARMACOLOGY, 2003, 69 (01) : 51 - 58
  • [37] SOME NOVEL 5-HYDROXYTRYPTAMINE(1A) (5-HT1A) RECEPTOR AGONISTS REDUCE GASTRIC-ACID AND PEPSIN-SECRETION, REDUCE EXPERIMENTAL GASTRIC-MUCOSAL INJURY AND ENHANCE GASTRIC MUCUS IN RATS
    FARRE, AJ
    COLOMBO, M
    ALVAREZ, I
    GLAVIN, GB
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1995, 272 (02): : 832 - 837
  • [38] EFFECT OF A NEW POTENT H2-RECEPTOR ANTAGONIST 3[[[2-[(DIAMINOMETHYLENE)AMINO]-4-THIAZOLYL]METHYL]THIO]-N-2-SULFAMOYLPROPIONAMIDINE (YM-11170) ON GASTRIC-MUCOSAL HISTAMINE-SENSITIVE ADENYLATE-CYCLASE FROM GUINEA-PIG
    HARADA, M
    TERAI, M
    MAENO, H
    BIOCHEMICAL PHARMACOLOGY, 1983, 32 (10) : 1635 - 1640
  • [39] A DOPAMINE D-3 RECEPTOR AGONIST, 7-HYDROXY-N,N-DI-N-PROPYL-2-AMINOTETRALIN REDUCES GASTRIC-ACID AND PEPSIN-SECRETION AND EXPERIMENTAL GASTRIC-MUCOSAL INJURY IN RATS
    GLAVIN, GB
    LIFE SCIENCES, 1994, 56 (04) : 287 - 293
  • [40] EFFECTS OF THE NEW HISTAMINE H-2-RECEPTOR ANTAGONIST N-ETHYL-N'-[3-[3-(PIPERIDINOMETHYL)PHENOXY]PROPYL]UREA WITH POTENT GASTRIC-MUCOSAL PROTECTIVE ACTIVITY ON ACUTE GASTRIC-LESIONS AND DUODENAL-ULCERS IN RATS
    SEKIGUCHI, H
    HAMADA, K
    TAGA, F
    NISHINO, K
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1993, 43-1 (02): : 134 - 138